Tag: United States Patent and Trademark Office

May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
May 7, 2018

International Stem Cell Corporation Granted Key Patent in US

International Stem Cell Corporation (OTCQB:ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that...
April 29, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 16, 2018

Mastercard Turns to Blockchain for Cracking Down on Fake IDs

The credit card company filed a blockchain patent solution to protect identity data with the US Patent and Trademark Office...
April 13, 2018

Cannabis Weekly Round-Up: John Boehner Joins the Cannabis Industry

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 11, 2018

EyeGate Issued New Patent for Iontophoretic Contact Lens Technology

EyeGate Pharmaceuticals (NASDAQ:EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the...
April 11, 2018

Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for Cannabinoid Delivery and Updates its Expanding Patent Portfolio

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), a drug delivery platform innovator, announces it has received another new Notice of Allowance from the...
March 27, 2018

NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform

Biotechnology leader NanoSphere Health Sciences, LLC (CSE:NSHS) is pleased to announce the United States Patent and Trademark Office has granted...